摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[1-[2-[1-(4-hydroxy-3-hydroxymethylbutyl)cyclohexyl]ethyl]piperidin-4-yl]-N-(5-methylpyridin-2-yl)-2-furancarboxamide | 518284-91-8

中文名称
——
中文别名
——
英文名称
N-[1-[2-[1-(4-hydroxy-3-hydroxymethylbutyl)cyclohexyl]ethyl]piperidin-4-yl]-N-(5-methylpyridin-2-yl)-2-furancarboxamide
英文别名
N-[1-[2-[1-[4-hydroxy-3-(hydroxymethyl)butyl]cyclohexyl]ethyl]piperidin-4-yl]-N-(5-methylpyridin-2-yl)furan-2-carboxamide
N-[1-[2-[1-(4-hydroxy-3-hydroxymethylbutyl)cyclohexyl]ethyl]piperidin-4-yl]-N-(5-methylpyridin-2-yl)-2-furancarboxamide化学式
CAS
518284-91-8
化学式
C29H43N3O4
mdl
——
分子量
497.678
InChiKey
BZOTYVQRCBLAJF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.3
  • 重原子数:
    36
  • 可旋转键数:
    11
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.66
  • 拓扑面积:
    90
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    sodium;hydrideN-[1-[2-[1-(4-hydroxy-3-hydroxymethylbutyl)cyclohexyl]ethyl]piperidin-4-yl]-N-(5-methylpyridin-2-yl)-2-furancarboxamide碘甲烷碳酸氢钠 在 ice 、 氯化钠magnesium sulfate 、 silica gel 、 silica 、 正己烷乙酸乙酯 、 1-chloroform 、 甲醇 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 1.67h, 以to obtain the title compound (100 mg)的产率得到N-[1-[2-[1-(4-methoxy-3-methoxymethylbutyl)cyclohexyl]ethyl]piperidin-4-yl]-N-(5-methylpyridin-2-yl)-2-furancarboxamide
    参考文献:
    名称:
    4-(2-Furoyl) aminopiperidine compound useful as therapeutic agent for itching
    摘要:
    提供了以下通式(I)所代表的化合物:[其中R1为5-甲基吡啶-2-基、对甲基苯基或二甲基苯基,R2为以下通式(II)-(IX)之一:(其中R3为C1-C4烷基,R4为H或C1-C4烷基,R5为H、3-吡啶甲基或4-吡啶甲基,R6为2,4-二羟基苯甲基、3-吡啶甲基或4-吡啶甲基),或当R1为二甲基苯基时,R2为以下通式(X)],以及其药学上可接受的盐。这些化合物具有抑制瘙痒作用,可用于预防或治疗由对昆虫造成的伤口反应、对环境过敏原的反应、皮肤感染或外部寄生虫感染引起的瘙痒和瘙痒,或透析患者引起的瘙痒。
    公开号:
    US20060270632A1
  • 作为产物:
    描述:
    N-[1-(2-[1-(4-methoxymethoxy)-3-(methoxymethoxymethyl)butyl]cyclohexyl)ethylpiperidin-4-yl]-N-(5-methylpyridin-2-yl)-2-furancarboxamide 在 盐酸 作用下, 以 甲醇 为溶剂, 反应 22.0h, 生成 N-[1-[2-[1-(4-hydroxy-3-hydroxymethylbutyl)cyclohexyl]ethyl]piperidin-4-yl]-N-(5-methylpyridin-2-yl)-2-furancarboxamide
    参考文献:
    名称:
    NOVEL 4-(2FUROYL)AMINOPIPERIDINES, INTERMEDIATES IN SYNTHESIZING THE SAME, PROCESS FOR PRODUCING THE SAME AND MEDICINAL USE OF THE SAME
    摘要:
    公开号:
    EP1443046B1
点击查看最新优质反应信息

文献信息

  • Novel 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
    申请人:Fukutomi Ryuuta
    公开号:US20050085508A1
    公开(公告)日:2005-04-21
    There are provided novel 4-(2-furoyl)aminopiperidines represented by the general formula (I), their synthetic intermediates, processes for their preparation and medicaments containing them. In the above formula, X is CH or N, and Y is a group of the following general formula (II), formula (II-a) or formula (III): wherein a, b and c are each an integer of 0-6; Z is CH 2 or NH; W is O or S; T is O or N—R 15 wherein R 15 is H, a C1-C6 alkyl group, a benzyl group or a phenethyl group; and R 1 is H, a C1-C6 alkoxycarbonyl group, a benzyloxycarbonyl group, or the like. The 4-(2-furoyl)aminopiperidine derivatives according to this invention possess opioid μ antagonistic activity and are useful for the treatment or prevention of side effects which are caused by μ receptors agonist and which are selected from constipation, nausea/emesis or itch, or for the treatment or prevention of idiopathic constipation, postoperative ileus, paralytic ileus, irritable bowel syndrome or chronic pruritus.
    提供了一种新的4-(2-呋喃酰基)哌啶化合物,其通式表示为(I),以及它们的合成中间体、制备过程和含有它们的药物。 在上述式中,X为CH或N,Y为以下通式(II)、式(II-a)或式(III)的基团: 其中a、b和c均为0-6的整数;Z为CH2或NH;W为O或S;T为O或N—R15,其中R15为H、C1-C6烷基、苄基或苯乙基;R1为H、C1-C6烷氧羰基、苄氧羰基或类似基团。本发明所述的4-(2-呋喃酰基)哌啶生物具有阿片μ受体拮抗活性,可用于治疗或预防由μ受体激动剂引起的副作用,包括便秘、恶心/呕吐或瘙痒,或用于治疗或预防特发性便秘、术后肠梗阻、麻痹性肠梗阻、肠易激综合征或慢性瘙痒。
  • Novel 4-(2-furoyl) aminopiperidienes, intermediates for synthesizing the same, processes for preparing the same and medicinal use of the same
    申请人:Fukutomi Ryuuta
    公开号:US20080194826A1
    公开(公告)日:2008-08-14
    A compound represented the general formula (V): wherein X is CH or N; and Y a is a group of the general formula selected from:
    一个化合物的一般式表示为(V):其中X是CH或N; 而Y是从一般式中选择的一个基团:
  • 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
    申请人:Kyorin Pharmaceutical Co., Ltd.
    公开号:US07375115B2
    公开(公告)日:2008-05-20
    There are provided novel 4(2-furoyl)aminopiperidines represented by the general formula (I), their synthetic intermediates, processes for their preparation and medicaments containing them. In the above formula, X is OH or N, and Y is a group of the following general formula (II), formula (II-a) or formula (III): wherein a, b and c are each an integer of 0-6; Z is CH2 or NH; W is O or S; T is O or N—R15 wherein R15 is H, a C1-C6 alkyl group, a benzyl group or a phenethyl group; and R1 is H, a C1-C6 alkoxycarbonyl group, a benzyloxy-carbonyl group, or the like. The 4-(2-furoyl)aminopiperidine derivatives according to this invention possess opioid μ antagonistic activity and are useful for the treatment or prevention of side effects which are caused by μ receptors agonist and which are selected from constipation, nausea/emesis or itch, or for the treatment or prevention of idiopathic constipation, postoperative ileus, paralytic ileus, irritable bowel syndrome or chronic pruritus.
    提供了一种新型的4(2-呋喃基)哌啶,其通式为(I),以及它们的合成中间体、制备方法和含有它们的药物。在上述公式中,X为OH或N,而Y为以下通式(II)、公式(II-a)或公式(III)的一种:其中a、b和c均为0-6的整数;Z为CH2或NH;W为O或S;T为O或N-R15,其中R15为H、C1-C6烷基、苄基或苯乙基;而R1为H、C1-C6烷氧羰基、苄氧羰基或类似物。根据本发明的4-(2-呋喃基)哌啶生物具有阿片μ拮抗活性,并可用于治疗或预防由μ受体激动剂引起的副作用,包括便秘、恶心/呕吐或瘙痒,或用于治疗或预防特发性便秘、术后肠梗阻、麻痹性肠梗阻、肠易激综合征或慢性瘙痒。
  • 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching
    申请人:Kyorin Pharmaceutical Co., Ltd
    公开号:US07601843B2
    公开(公告)日:2009-10-13
    There are provided compounds represented by the following general formula (I): [where R1 is 5-methylpyridin-2-yl, p-tolyl or mesityl, R2 is one of the following general formulas (II)-(IX): (where R3 is C1-C4 alkyl, R4 is H or C1-C4 alkyl, R5 is H, 3-pyridylmethyl or 4-pyridylmethyl, and R6 is 2,4-dihydroxybenzyl, 3-pyridylmethyl or 4-pyridylmethyl), or when R1 is mesityl, R2 is the following formula (X)], and pharmaceutically acceptable salts thereof. The compounds exhibit pruritus-inhibiting action, and are useful for prevention or of itching and pruritus caused by reaction against insect-inflicted wounds, reaction against environmental allergens, skin infections or external parasite infections, or caused to renal dialysis patient.
    以下是通用式(I)所代表的化合物:[其中R1是5-甲基吡啶-2-基,对甲基苯基或三甲基苯基,R2是以下通用式(II)-(IX)之一:(其中R3是C1-C4烷基,R4是H或C1-C4烷基,R5是H,3-吡啶甲基或4-吡啶甲基,R6是2,4-二羟基苯甲基,3-吡啶甲基或4-吡啶甲基),或当R1是三甲基苯基时,R2是以下式子(X)],以及其药学上可接受的盐。这些化合物具有止痒作用,可用于预防或治疗由昆虫叮咬引起的瘙痒和瘙痒反应,环境过敏原引起的反应,皮肤感染或外部寄生虫感染引起的瘙痒,或透析患者引起的瘙痒。
  • 4-(2-FUROYL)AMINOPIPERIDINE COMPOUND USEFUL AS THERAPEUTIC AGENT FOR ITCHING
    申请人:KYORIN PHARMACEUTICAL CO., LTD.
    公开号:EP1621538A1
    公开(公告)日:2006-02-01
    There are provided compounds represented by the following general formula (I): [where R1 is 5-methylpyridin-2-yl, p-tolyl or mesityl, R2 is one of the following general formulas (II)-(IX): (where R3 is C1-C4 alkyl, R4 is H or C1-C4 alkyl, R5 is H, 3-pyridylmethyl or 4-pyridylmethyl, and R6 is 2,4-dihydroxybenzyl, 3-pyridylmethyl or 4-pyridylmethyl), or when R1 is mesityl, R2 is the following formula (X)], and pharmaceutically acceptable salts thereof. The compounds exhibit pruritus-inhibiting action, and are useful for prevention or treatment of itching and pruritus caused by reaction against insect-inflicted wounds, reaction against environmental allergens, skin infections or external parasite infections, or caused to renal dialysis patient.
    本发明提供了由以下通式 (I) 代表的化合物: [其中 R1 为 5-甲基吡啶-2-基、对甲苯基或间甲基,R2 为以下通式 (II)-(IX) 之一: (其中 R3 是 C1-C4 烷基,R4 是 H 或 C1-C4 烷基,R5 是 H、3-吡啶甲基或 4-吡啶甲基,R6 是 2,4-二羟基苄基、3-吡啶甲基或 4-吡啶甲基)、 或当 R1 为甲苯甲基时,R2 为下式 (X)]、 及其药学上可接受的盐类。这些化合物具有抑制瘙痒的作用,可用于预防或治疗由昆虫造成的伤口反应、环境过敏原反应、皮肤感染或体外寄生虫感染引起的瘙痒,或肾透析患者引起的瘙痒。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-